1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 SCOPE OF THE STUDY
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 UNITS CONSIDERED
1.6 STAKEHOLDERS
1.7 INCLUSIONS & EXCLUSIONS
1.8 SUMMARY OF CHANGES
1.8.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 FORECAST ESTIMATION
2.6 LIMITATIONS
2.7 RECESSION IMPACT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 PHARMACEUTICAL PACKAGING MARKET IN 2022
4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
4.3 PHARMACEUTICAL PACKAGING MARKET, BY END-USE INDUSTRY
4.4 PHARMACEUTICAL PACKAGING MARKET GROWTH RATE, BY COUNTRY

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 VALUE CHAIN ANALYSIS
5.3.1 RAW MATERIAL SUPPLIERS
5.3.2 R&D OF PRODUCTS
5.3.3 MANUFACTURERS
5.3.4 DISTRIBUTORS
5.3.5 END-USERS
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 BARGAINING POWER OF SUPPLIERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 CASE STUDY ANALYSIS
5.6 MACROECONOMIC INDICATORS
5.7 TARIFF & REGULATORY LANDSCAPE
5.7.1 REGULATIONS
5.7.2 STANDARDS
5.7.3 REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
5.8 TECHNOLOGY ANALYSIS
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END-USE INDUSTRY
5.9.2 AVERAGE SELLING PRICE TREND, BY REGION
5.10 ECOSYSTEM / MARKET MAP
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESSES
5.12 PATENT ANALYSIS
5.13 RAW MATERIAL ANALYSIS
5.13.1 PLASTICS
5.13.2 PAPER
5.13.3 GLASS
5.13.4 METAL
5.14 TRADE ANALYSIS
5.14.1 EXPORT SCENARIO
5.14.2 IMPORT SCENARIO
5.15 KEY CONFERENCES & EVENTS (2024-2025)
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 BUYING CRITERIA

6 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
6.1 INTRODUCTION
6.2 PLASTICS
6.2.1 HIGH-DENSITY POLYETHYLENE
6.2.2 POLYESTER
6.2.3 POLYPROPYLENE
6.2.4 LOW-DENSITY POLYETHYLENE
6.2.5 POLYVINYL CHLORIDE
6.2.6 CYCLIC OLEFIN COPOLYMER
6.2.7 POLYETHYLENE TEREPHTHALATE
6.3 PAPER & PAPERBOARD
6.4 GLASS
6.5 METALS
6.6 OTHERS

7 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
7.1 INTRODUCTION
7.2 PLASTIC BOTTLES
7.2.1 STANDARD PLASTIC BOTTLES
7.2.2 PLASTIC DISPENSING BOTTLES
7.2.3 PLASTIC JARS
7.3 BLISTER PACKS
7.3.1 COMPARTMENT PACKS
7.3.2 WALLET PACKS
7.4 LABELS & ACCESSORIES
7.4.1 SELF-ADHESIVE
7.4.2 DIE CUT
7.4.3 HOLOGRAPHIC STRIP
7.4.4 TAMPER PROOF
7.4.5 OTHERS
7.5 CAPS & CLOSURES
7.6 MEDICAL SPECIALTY BAGS
7.7 PRE-FILLED SYRINGES
7.8 TEMPERATURE CONTROLLED PACKAGING
7.9 POUCHES & STRIP PACKS
7.10 AMPOULES
7.11 VIALS
7.12 PRE-FILLED INHALERS
7.12.1 METERED DOSE INHALERS
7.12.2 DRY POWDER INHALERS
7.13 MEDICATION TUBES
7.13.1 COMPOSITE TUBES
7.13.2 ALL-PLASTIC TUBES
7.13.3 COLLAPSIBLE METAL TUBES
7.14 JARS & CANISTERS
7.15 CARTRIDGES
7.16 OTHERS

8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
8.1 INTRODUCTION
8.2 ORAL
8.3 PULMONARY
8.4 TRANSDERMAL
8.5 INJECTABLE
8.6 TOPICAL
8.7 NASAL
8.8 OCULAR/OPHTHALMIC
8.9 IV DRUGS
8.10 OTHERS

9 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE
9.1 INTRODUCTION
9.2 PRIMARY
9.3 SECONDARY

10 PHARMACEUTICAL PACKAGING MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 RECESSION IMPACT
10.2.2 US
10.2.3 CANADA
10.2.4 MEXICO
10.3 EUROPE
10.3.1 RECESSION IMPACT
10.3.2 GERMANY
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 UK
10.3.6 SPAIN
10.3.7 RUSSIA
10.3.8 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 RECESSION IMPACT
10.4.2 CHINA
10.4.3 JAPAN
10.4.4 SOUTH KOREA
10.4.5 INDIA
10.4.6 AUSTRALIA
10.4.7 REST OF ASIA PACIFIC
10.5 SOUTH AMERICA
10.5.1 RECESSION IMPACT
10.5.2 BRAZIL
10.5.3 ARGENTINA
10.5.4 REST OF SOUTH AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 RECESSION IMPACT
10.6.2 GCC COUNTRIES
10.6.2.1 UAE
10.6.2.2 SAUDI ARABIA
10.6.2.3 REST OF GCC
10.6.3 SOUTH AFRICA
10.6.4 REST OF THE MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
11.1 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.1.1 OVERVIEW OF STRATEGIES DEPLOYED
11.2 MARKET SHARE ANALYSIS
11.2.1 RANKING OF KEY MARKET PLAYERS
11.2.2 MARKET SHARE OF KEY PLAYERS, 2022
11.3 REVENUE ANALYSIS
11.4 COMPANY EVALUATION MATRIX, 2022
11.4.1 STARS
11.4.2 EMERGING LEADERS
11.4.3 PERVASIVE PLAYERS
11.4.4 PARTICIPANTS
11.4.5 COMPANY FOOTPRINT
11.5 START-UP/SME EVALUATION MATRIX
11.5.1 PROGRESSIVE COMPANIES
11.5.2 RESPONSIVE COMPANIES
11.5.3 DYNAMIC COMPANIES
11.5.4 STARTING BLOCKS
11.5.5 COMPETITIVE BENCHMARKING
11.6 COMPETITIVE SCENARIO AND TRENDS
11.6.1 NEW PRODUCT LAUNCHES
11.6.2 DEALS
11.6.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, Current Focus and Strategies, Threat from Competition, and Right to Win) *
12.1 BERRY GLOBAL INC.
12.2.1 Business overview
12.2.2 Products Offered
12.2.3 Recent Developments
12.2.4 MnM view
12.2.4.1 Key strengths/right to win
12.2.4.2 Strategic choices made
12.2.4.3 Weaknesses and Competitive Threats
12.2 GERRESHEIMER AG
12.3 AMCOR PLC
12.4 SCHOTT AG
12.5 APTARGROUP, INC.
12.6 BECTON, DICKINSON AND COMPANY
12.7 CATALENT, INC.
12.8 NIPRO CORPORATION
12.9 WEST PHARMACEUTICAL SERVICES, INC.
12.10 WESTROCK COMPANY
12.11 OTHER PLAYERS
12.11.1 ALPLA WERKE ALWIN LEHNER GMBH & CO KG
12.11.2 ARDAGH GROUP S. A.
12.11.3 CCL INDUSTRIES INC.
12.11.4 FRANK NOE EGYPT LTD
12.11.5 GAPLAST GMBH
12.11.6 LONZA GROUP LTD
12.11.7 MONDI GROUP
12.11.8 NOLATO AB
12.11.9 ORIGIN PHARMA PACKAGING
12.11.10 COMAR
12.11.11 PAREKHPLAST INDIA LTD.
12.11.12 SGD PHARMA
12.11.13 SILGAN HOLDINGS INC.
12.11.14 STEVANATO GROUP
12.11.15 VETTER PHARMA INTERNATIONAL GMBH

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS